01:45:47 EST Wed 17 Dec 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Z:APUS - APIMEDS PHARMACEUTICALS US INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
APUS - Z0.11.99·2.150.12.05+0.031.521.840782.0706  2.13  2.044.031  1.3719:29:42Dec 1015 min RT 2¢

Recent Trades - Last 10 of 78
Time ETExPriceChangeVolume
19:29:42Z2.09120.0112800
19:29:42Z2.08010.000187
19:29:42Z2.08 87
19:18:02Z2.1080.028300
18:52:47Z2.150.07411
18:37:49Z2.140.061
16:10:04Z2.05-0.031
16:10:04Z2.05-0.031
15:59:53Z2.1150.03225
15:59:17Z2.0850.0052

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-12-10 09:58U:APUSNews ReleaseApimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy
2025-12-01 09:25U:APUSNews ReleaseApimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE
2025-11-10 10:00U:APUSNews ReleaseApimeds Brings ai Superscript 2 Futures Lab(TM) to the Palouse - Partnering with the University of Idaho to Shape the Future of Biotech Innovation
2025-10-14 03:02U:APUSNews ReleaseApimeds Pharmaceuticals says "I love my Ducks" with new ai Superscript 2 Futures Lab(TM) Program collaboration with the University of Oregon's Lundquist College of Business
2025-09-15 18:24U:APUSNews ReleaseApimeds Expands ai Superscript 2 Future Labs Program to Include University of San Diego Students in Biotech Business Development
2025-09-11 21:54U:APUSNews ReleaseApimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program
2025-08-25 14:11U:APUSNews ReleaseApimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai Superscript 2 Future Labs
2025-07-15 17:34U:APUSNews ReleaseApimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai Superscript 2 Division
2025-05-12 17:14U:APUSNews ReleaseApimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
2025-05-08 17:00U:APUSNews ReleaseApimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering